Recruitment for Pivotal Phase II IBS Clinical Trial Stage 2
Filed with ASX · · 4 pages · English
Anatara Lifesciences Ltd on 6ix
Earlier from Anatara Lifesciences
- Appendix 4D & Half Year Report 31 December 2023
- Appendix 4C & Q2 FY24 Activities Report
- Entitlement Offer Results
- Non-Renounceable Entitlement Offer Booklet
- Entitlement offer opens and dispatch of Offer Booklet
Later from Anatara Lifesciences
- Anatara successful placement for $1.0M
- Appendix 4C & Q4 FY24 Activities Report
- Appendix 4E & Financial Report 30 June 2024
- $626,000 received in R&D Tax Incentive for FY24
- GaRP Irritable Bowel Syndrome Clinical Trial Update
Follow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences